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ApoptosisA pathological hallmark of Alzheimer disease (AD) is the accumulation of misfolded hyperphosphorylated
microtubule-associated protein Tau within neurons, forming neuroﬁbrillary tangles and leading to synaptic dys-
function and neuronal death. Here we study sequence-dependent abnormal aggregation of human fragment
Tau244–372 in an inducible cell model. As evidenced by confocal laser scanning microscopy, Western blot, and
immunogold electron microscopy, ﬁbril-forming motifs are essential and sufﬁcient for abnormal aggregation of
Tau244–372 in SH-SY5Y neuroblastoma cells induced by Congo red: when its two ﬁbril-forming segments PHF6
and PHF6* are deleted, Tau244–372 does lose its ability to form ﬁbrils in SH-SY5Y cells, and the replacement of
PHF6 and PHF6* with an unrelated amyloidogenic sequence IFQINS from human lysozyme does rescue the
ﬁbril-forming ability of Tau244–372 in SH-SY5Y cells. By contrast, insertion of a non-ﬁbril forming peptide GGGG
GG does not drive the disabled Tau244–372 to misfold in SH-SY5Y cells. Furthermore, as revealed by quantum
dots based probes combinedwith annexin V staining, annexin V-FITC apoptosis detection assay, and immunoﬂu-
orescence, ﬁbril-formingmotifs are essential and sufﬁcient for early apoptosis of living SH-SY5Y cells induced by
abnormal aggregation of Tau244–372. Our results suggest that ﬁbril-forming motifs could be the determinants of
Tau protein tending to misfold in living cells, thereby inducing neuronal apoptosis and causing the initiation
and development of AD.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
A pathological hallmark of Alzheimer disease (AD) and Pick disease
is the accumulation of misfolded hyperphosphorylated microtubule-
associated protein Tau within neurons, forming neuroﬁbrillary tangles
and leading to synaptic dysfunction and neuronal death [1–5]. AD and
Pick disease are progressive and irreversible neurodegenerative dis-
eases caused by the ﬁbrillization of human Tau protein in cells [5], and
have posed a serious threat to human health. The most important 125
scientiﬁc questions we want to address in the next 100 years have
been put forward in Science nine years ago, one of which is “to what ex-
tent can we stave off Alzheimer disease?” [6]. There is no efﬁcient treat-
ment available for AD and Pick disease and their mechanism is not well
understood so far [5]. Thus the characterization of factors regulating
Tau protein ﬁbrillization is of great importance to clarify the etiologysion electron microscopy; ThT,
propidium iodide
rology, College of Life Sciences,
7 68754902.of AD and Pick disease and to assist in the establishment of medical
treatment [7–12].
What are the key factors causing more than 20 amyloidogenic pro-
teins to misfold in cells, thereby leading to numerous neurodegenera-
tive diseases? The Eisenberg lab has provided the ﬁrst demonstration
that ﬁbril-forming motifs identiﬁed from amyloidogenic proteins form
the core of amyloid ﬁbrils [13,14], and has developed a structure-
based, computational approach to identifying these motifs [15]. Such
ﬁbril-forming segments themselves can form amyloid ﬁbrils in vitro,
their atomic structures reveal tightly packed β-sheets with steric zipper
interfaces characteristic of the amyloid state [13,14], and they can force
a non-ﬁbrillizing protein to form amyloid ﬁbrils [16]. Furthermore, the
Eisenberg lab has recently used the atomic structures of ﬁbril-forming
motifs as templates, designed an all-D-amino-acid inhibitor of Tau
ﬁbrillization [17], and found that amyloid β-sheet mimics containing
ﬁbril-forming segments can inhibit the aggregation of amyloidogenic
proteins and reduce amyloid toxicity [18]. Although it has been
previously demonstrated that two ﬁbril-forming motifs 275VQIINK280
(PHF6*) and 306VQIVYK311 (PHF6) are essential and sufﬁcient for the
ﬁbrillization of human Tau in vitro[19–21], we do not know whether
such motifs are also important for abnormal aggregation of human
Tau protein in vivo and thereby induce AD and Pick disease.
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bule binding domain of human Tau forming the core of neuroﬁbrillary
tangles in AD, and can form ﬁbrils with the help of the polyanion induc-
er heparin in vitro in a relatively short time [8–10,17,19–24]. Anionic
dyes such as Congo red are also able to induce Tau ﬁbrillization
in vitro[25,26]. Furthermore, Congo red has been used to induce abnor-
mal aggregation of human Tau protein in both HEK-293 cells and
SH-SY5Y neuroblastoma cells [26,27].
Semiconductor quantum dots (Q-dots), with high broad excita-
tion spectra, high brightness, superior photostability, resistance to
photobleaching, and non-toxicity, have fascinated biologists over the
last few years as optical labeling nanomaterials [28,29]. Atomic identiﬁ-
cation of ﬂuorescent Q-dots on Tau-positive ﬁbrils in 3D-reconstructed
Pick bodies has been reported recently [30].
In this study, we ﬁrstly studied sequence-dependent abnormal
aggregation of human Tau protein in an inducible cell model by using
Congo red as the agonist. Congo red, an aromatic heterocycle, is capable
of inducing Tau ﬁbrillization both in vitro and in vivo for its transmem-
brane property [25–27]. Therefore, we built an inducible cell model to
demonstrate for the ﬁrst time that ﬁbril-forming motifs are essential
and sufﬁcient for the ﬁbrillization of human Tau244–372 in SH-SY5Y
cells by using Congo red binding assays, confocal laser scanningmicros-
copy, transmission electron microscopy (TEM), and immunogold
electron microscopy. Furthermore, insertion of a ﬁbril-forming peptide
IFQINS from human lysozyme (an aggregation competent motif
[13,15]) did drive but insertion of non-ﬁbril forming peptide GGGGGG
(an aggregation incompetent motif [16]) did not drive the disabled
Tau244–372 to form ﬁbrils in SH-SY5Y cells, implicating that ﬁbril-
forming motifs could be the determinants of Tau protein tending
to misfold in vivo, thereby causing the initiation and development
of AD and Pick disease. We thus suggest that sequence-dependent
aggregation could be a key mechanism for the misfolding of many
amyloidogenic proteins.2. Materials and methods
2.1. Materials
Congo red (fresh molecular weight of 696.67), thioﬂavin T (ThT),
and thioﬂavin S (ThS) were from Sigma-Aldrich (St. Louis, MO).
Dithiothreitol (DTT) was obtained from Amresco (Solon, OH). DNA po-
lymerase Kod-plus-Neo was from Toyobo (Tokyo, Japan). Anti-FLAG
monoclonal antibody and 10-nm gold-labeled anti-mouse antibody
were purchased from Sigma-Aldrich (St. Louis, MO). Mouse anti-Tau
(TAU-5) monoclonal antibody was Santa Cruz Biotechnology products
(Santa Cruz, CA). Alexa 546-conjugated goat anti-mouse IgG secondary
antibody was from Invitrogen (Carlsbad, CA). Other chemicals used
were made in China and of analytical grade.2.2. Plasmids and proteins
The construction of prokaryotic plasmid expressing Tau244–372 and
its mutants, and Tau protein puriﬁcation were carried as described
[8–10,19].2.3. Cell culture and transfection
SH-SY5Y neuroblastoma cells were cultured in Dulbecco's modiﬁed
Eagle's medium supplemented with 10% (v/v) fetal bovine serum
(FBS), 100 U/ml penicillin, and 100 U/ml streptomycin in 5% CO2 at
37 °C. SH-SY5Y cells were transiently transfected with FLAG-tagged
human Tau in pCMV-Tag 2B vector using Lipofectamine® 2000
(Invitrogen, Carlsbad, CA) according to the manufacturer's protocol.2.4. Plasmid and stable cell line construction
SH-SY5Y cell line stably expressing FLAG-tagged human
Tau244–372ΔK280 (stable Tau244–372ΔK280-FLAG cells) was constructed
with lentiviral vector construction system. Human Tau244–372ΔK280 was
cloned into a lentiviral vector pHAGE-puro by Mlu I and BamH I restric-
tion sites. Lentiviral vector construction system constructed with CMV
promoter was packaged in HEK293T cells by various combinations of
plasmids and liposome, the three plasmids pHAGE-Tau244–372ΔK280,
pVSVG, and pLP were mixed at a ratio of 2:1:1 and the ratio of liposome
to DNA was 2:1. After 36 h transfection, we harvested the virus, and
then SH-SY5Y cells were infected by the packaged lentivirus with a high
infection efﬁciency detected by Western blot.
2.5. Congo red binding assays
A stock solution of 200 μMCongo redwas prepared in 10mMHEPES
buffer (pH 7.4) containing 100 mM NaCl. This solution was ﬁltered
through a 0.22 μm pore size ﬁlter before use 5 μM Tau protein (wild-
type Tau244–372 and its mutants) was incubated in 10mMHEPES buffer
(pH 7.4) containing 2 mM DTT and 100 mM NaCl in the presence of
50 μM Congo red, and Tau aggregation analysis in vitrowas carried out
at 37 °C. To mimic the reducing environment present in normal neuro-
nal cells and block the formation of an intramolecular disulﬁde bond in
Tau protein, 2 mMDTTwas added into the buffer. The ultraviolet absor-
bance spectra of such Tau aggregation induced by Congo redwere set up
by amixture of 5 μMTau protein and 50 μMCongo red in 10mMHEPES
buffer. The reaction components weremixed quickly and read for 0 and
12 h at 37 °C, recording the absorbance spectra from 650 nm to 400 nm
on a UV-2550 Probe spectrophotometer (Shimadzu, Kyoto, Japan).
The polymerization induced by Congo red for Tau244–372 in 96-well
plates was set up by a mixture of 10 μM Tau protein, in the presence
of 0, 5, 10, 20, 50, 80, 100 and 150 μMCongo red in 10mMHEPES buffer
containing 2 mM DTT and 100 mMNaCl (pH 7.4). The reaction compo-
nents were mixed quickly and immediately read for 10 h at 37 °C in a
SpectraMax M2 microplate reader (Molecular Devices, Sunnyvale, CA)
using absorbance at 550 nm. Each sample was run in triplicate.
Kinetic parameters were determined by ﬁtting the absorbance at
550 nm versus time to a sigmoidal equation [8,9,31,32],
A ¼ A0 þ Bþ ctð Þ= 1þ exp k tm−tð Þ½ f g ð1Þ
where A is the absorbance at 550 nm, k the rate constant for the growth
of ﬁbrils, and tm the time to 50% of maximal absorbance at 550 nm. A0
describes the initial baseline during the lag time. B + ct describes the
ﬁnal baseline after the growth phase has ended. The lag time is deter-
mined to be tm− 2 / k.
2.6. Transmission electron microscopy (TEM)
The formation of ﬁbrils by Tau244–372 and its mutants induced by
Congo red was conﬁrmed by electron microscopy of negatively stained
samples. Sample aliquots of 10 μl were placed on carbon-coated copper
grids (Shanghai Mainstream Trading Company, Shanghai, China), and
left at room temperature for 1–2 min, rinsed with H2O twice, and then
stained with 2% (w/v) uranyl acetate for another 1–2 min. The stained
samples were examined using an H-8100 transmission electron micro-
scope (Hitachi, Tokyo, Japan) operating at 100 kV or an FEI Tecnai G2 20
transmission electron microscope (Hillsboro, OR) operating at 200 kV.
2.7. Laser scanning confocal analysis
SH-SY5Y cells transiently over-expressing FLAG-tagged wild-type
Tau244–372, Tau244–372/ΔPHF6/ΔPHF6* inserted by IFQINS, Tau244–372/
ΔPHF6 (PHF6-deleted mutant), Tau244–372/ΔPHF6* (PHF6*-deleted
mutant), Tau244–372/ΔPHF6/ΔPHF6*, Tau244–372/ΔPHF6/ΔPHF6* inserted
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cells were cultured in medium containing 10 μM Congo red for 3 days,
planted onto the coverslips in the presence of 10 μM Congo red for
3 days, and then transfected with plasmids transiently. After 48 h, cells
were ﬁxed with paraformaldehyde, ruptured with 0.25% Triton-X 100,
stained with 250 μM ThT, coimmunostained with primary monoclonal
antibodies Anti-FLAG and secondary Alexa Fluo-546, and visualized by
confocal microscopy. Tau244–372ΔK280 stably expressed in SH-SY5Y
cells formed aggregates in the cells in the absence of Congo red.
SH-SY5Y cell line stably expressing human Tau244–372ΔK280 tagged
with FLAG (stable Tau244–372ΔK280-FLAG cells) was grown on glass
coverslips for 5 days and analyzed for protein aggregation. For confocal
microscopy analysis, cells were ﬁxed with paraformaldehyde, ruptured
with 0.25% Triton-X 100, stained with 0.1% ThS, coimmunostained with
primary monoclonal antibodies Anti-FLAG or TAU-5 and secondary
Alexa Fluo-546, and visualized by confocal microscopy. Images were
captured using an Olympus FluoView FV1000 laser scanning confocal
microscope (Tokyo, Japan). Green ﬂuorescence was detected using the
488-nm laser line of an Argon laser, and red ﬂuorescence was detected
using the 559-nm laser line of the HeNe laser.
SH-SY5Y cells were incubated with Q-dots labeled Tau or Q-dots
alone in Opti-MEM culture medium for 4 h. After 4 h, SH-SY5Y cells
were washed with PBS buffer twice and incubated with a fresh cell
culture medium. Olympus FluoView FV1000 ﬂuorescence microscope
was then used to observe Q-dots in living SH-SY5Y cells.
2.8. Western blot
SH-SY5Y cellswere cultured inmedium containing 10 μMCongo red
for 3 days, planted onto the coverslips in the presence of 10 μM Congo
red for 3 days, and then transfected with plasmids transiently. After
48 h, cells were harvested, half was lysed, and then separated into
supernatant and pellet fractions by ultracentrifugation at 15,000 g for
20 min, while the other half was lysed to get whole cell lysis buffer.
Whole cell lysis buffer and ultracentrifugation pellets were boiled in
SDS-PAGE loading buffer, respectively, subjected to 13.5% SDS-PAGE
and transferred onto polyvinylidene diﬂuoride membranes (Millipore,
Billerica, MA), and blocked with 5% fat-freemilk in 25mMTris bufferedFig. 1. Fibril-forming motifs are essential and sufﬁcient for the ﬁbrillization of human Tau244–3
5 μM wild-type Tau244–372 in the presence of 50 μM Congo red at 0 h (a) and 2 h (b), respe
of PHF6 (positive insertionmutant) in the presence of 50 μMCongo red at 0 h (c) and 12 h (d), res
deletionmutant) was incubatedwith 50 μMCongo red at 0 h (e) and 12 h (f), respectively, or 5 μM
mutant) was incubated with 50 μMCongo red at 0 h (g) and 12 h (h), respectively. In each panel,
(3) and Congo red alone (1) from those of Tau + Congo red (2). Congo red binding assays weresaline buffer mixed with 0.047% Tween 20. Western blot of whole
cell lysis buffer was carried out by usingmonoclonal anti-FLAG primary
antibody (Sigma-Aldrich) at a dilution of 1:1000 and anti-actin
primary antibody (BeyoECL Plus, Beyotime, Nantong, China) at a dilu-
tion of 1:1000 separately, followed by goat anti-mouse horseradish
peroxidase-conjugated secondary antibody at a dilution of 1:2000.
Western blot of pellets was carried out by using monoclonal anti-FLAG
primary antibody at a dilution of 1:1000, followed by goat anti-mouse
horseradish peroxidase-conjugated secondary antibody at a dilution
of 1:2000. Immunoreactive bands were visualized using enhanced
chemiluminescence (BeyoECL Plus, Beyotime, Nantong, China).
2.9. Immunoelectron microscopy
SH-SY5Y cells were homogenized in ice-cold buffer H (10 mM
Tris–HCl, 1 mM EGTA, 0.8 M NaCl, 10% sucrose and protease inhibitor
mixture, pH 7.4), and centrifuged for 20min at 20,000 g. Pellet fractions
were discarded, while supernatant fractions (S1) were saved and incu-
batedwith 1% Sarkosyl for half an hour at room temperaturewith agita-
tion. After centrifugation of themixture (1 h at 100,000 g), the resultant
pellets were re-suspended in 30 mM Tris–HCl (pH 7.4). Aliquots were
absorbed onto Formvar/carbon-coated grids and incubated with the
Anti-FLAG monoclonal antibody (primary antibody) for 30 min at
37 °C. After washing with 0.1% bovine serum albumin, grids were incu-
bated with the 10-nm gold-labeled goat anti-mouse monoclonal anti-
body (secondary antibody). Samples were then stained with 2% uranyl
acetate for 1 min, and viewed by electron microscopy (Hillsboro, OR).
2.10. Quantum dots based probes combined with Annexin V staining
SH-SY5Y cells were cultured inmedium containing 10 μMCongo red
for 7 days, planted onto themini-dishes in the presence of 10 μMCongo
red overnight. Q-dots conjugated Streptavidin were linked to biotin
marked Tau monomers at 4 °C for 10 min, then incubate the SH-SY5Y
cells in Opti-MEM culture medium for 4 h, change fresh cell culture
medium containing 10 μM Congo red, after 12 h, cells were stained
with Annexin V-FITC, observed by laser scanning confocal microscopy
(Tokyo, Japan).72 — Congo red binding assays. Absorbance data are shown for amyloid ﬁbril formation of
ctively, and that of 5 μM Tau244–372/ΔPHF6/ΔPHF6* inserted by IFQINS at the location
pectively. No aggregationwas detectedwhen either 5 μMTau244–372/ΔPHF6/ΔPHF6* (double
Tau244–372/ΔPHF6/ΔPHF6* inserted by GGGGGG at the location of PHF6 (negative insertion
the difference spectra (4) were obtained by subtracting the absorbance spectra of Tau alone
carried out at 37 °C.
Fig. 3. Fibril-formingmotifs are essential and sufﬁcient for theﬁbrillization of humanTau244–372— kinetic analyses basedon absorbance data at 550 nm. Kinetic curves for the aggregation of
5 μMwild-type Tau244–372 (a) and 5 μM Tau244–372/ΔPHF6/ΔPHF6* inserted by IFQINS at the location of PHF6 (b), incubated with 50 μM Congo red. A sigmoidal equation was ﬁtted to all
data (open circles). No aggregation was detected when either 5 μM Tau244–372/ΔPHF6/ΔPHF6* was incubated with 50 μM Congo red up to 12 h (c) or 5 μM Tau244–372/ΔPHF6/ΔPHF6*
inserted by GGGGGG at the location of PHF6 was incubated with 50 μM Congo red up to 12 h (d). Absorbance data with error bars were expressed as mean ± S.D. of 3 independent
experiments. Congo red binding assays were carried out at 37 °C.
Fig. 2. The dependence of changes in the absorbance at 550 nm for Tau244–372 ﬁlament
formation at 37 °C on the molar ratio of Congo red to Tau protein. The concentrations of
Tau244–372 and DTT were 10 μM and 2 mM, respectively. The molar ratio of Congo red to
Tau244–372 was 1:2 (ﬁlled circle), 1:1 (ﬁlled square), 2:1 (ﬁlled triangle), 5:1 (inverted
ﬁlled triangle), 8:1 (open square), 10:1 (left ﬁlled triangle), and 15:1 (right ﬁlled triangle),
respectively. 10 μM Tau244–372 alone (open circle) was as control. A sigmoidal equation
was ﬁtted to all data from replicates at each Congo red concentration.
Table 1
Kinetic parameters of Tau ﬁbrillization in the presence of different concentrations of
Congo red as determined by Congo red binding assays at 37 °C. Kinetic parameters, k, tm
and the lag time, were determined by ﬁtting the absorbance at 550 nm versus time in
Figs. 2 and 3 to Eq. (1). The ﬁnal concentration of Tau244–372 was 10 μM. The buffer used
was 10mMHEPES buffer (pH 7.4) containing 2 mMDTT and 100mMNaCl. Errors shown
are standard errors of the mean.
Tau Congo red k tm Lag time
μM 10−3 min−1 min min
Tau244–372 0 ~0a NAb NAb
5 155 ± 14 36.5 ± 2.6 23.6 ± 3.8
10 160 ± 15 27.2 ± 2.7 14.7 ± 3.9
20 187 ± 19 20.5 ± 2.5 9.8 ± 3.6
50 210 ± 29 14.8 ± 3.0 5.3 ± 4.3
80 208 ± 31 14.4 ± 3.3 4.8 ± 4.7
100 159 ± 19 17.2 ± 3.5 4.6 ± 5.0
150 61.1 ± 3.7 44.1 ± 4.4 11.4 ± 6.4
50c 139 ± 2 27.3 ± 0.5 12.9 ± 0.7
Positive insertion mutantd 50c 11.5 ± 0.7 407 ± 2 232 ± 13
Double deletion mutante 50c ~0a NAb NAb
Negative insertion mutantf 50c ~0a NAb NAb
a Observed from the absorbance spectra directly.
b No aggregation observed in the present conditions.
c The ﬁnal concentration of Tau protein was 5 μM.
d Tau244–372/ΔPHF6/ΔPHF6* inserted by IFQINS at the location of PHF6.
e Tau244–372/ΔPHF6/ΔPHF6*.
f Tau244–372/ΔPHF6/ΔPHF6* inserted by GGGGGG at the location of PHF6.
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Apoptotic cells were detected by ﬂow cytometry after staining
with Annexin V-FITC apoptosis detection kit (Beyotime, Nantong,
China). Brieﬂy, cells treated with Tau monomers were collected,
washed with PBS buffer and re-suspended in 195 μl of binding buffer
containing 5 μl annexin V-FITC, after 10 min of incubation in dark-
ness at room temperature, centrifugated at 1000 g for 5 min and
re-suspended in 190 μl of binding buffer containing 10 μl propidium
iodide (PI). Annexin V binding was analyzed by an EPICS XL-MCL
ﬂow cytometer (Beckman Coulter, Fullerton, CA). The percentage of
apoptotic cells was calculated from the total (~104 cells) using
EXPO32 MultiComp software (Beckman Coulter). Viable cells did
not bind annexin V or PI (lower left quadrant D3), early apoptotic
cells bound to annexin V but excluded PI (lower right quadrant
D4), and necrotic or late apoptotic cells were both annexin V- and
PI-positive (upper right quadrant D2). The upper left quadrant D1
contains the cells damaged during the preparation of the cell
suspension.Fig. 4. Fibril-formingmotifs are essential and sufﬁcient for theﬁbrillization of humanTau244–372—
Tau244–372 (a), 5 μMTau244–372/ΔPHF6/ΔPHF6* inserted by IFQINS at the location of PHF6 (b), 5
GG at the location of PHF6 (d), incubatedwith 50 μMCongo red at 37 °C for 45min (a) or 12 h (b
observed in c and d. All the scale bars were 200 nm.3. Results
3.1. Effect of Congo red on ﬁbril formation of human Tau protein in vitro
In this study, the effects of Congo red on ﬁlament formation of
human Tau fragment Tau244–372 were examined by Congo red binding
assays (Figs. 1–3 and S1). The following are the reasons why Congo
red was used from biological and pathological viewpoints. Firstly,
Congo red is a small molecule that acts as an inducer of Tau aggregation,
and the kinetic barrier to Tau ﬁbrillization can be overcome by Congo
red [25]. Secondly, Congo red is a well-known histological stain for
demonstrating the presence of amyloidosis in ﬁxed tissues by reacting
speciﬁcally with β-sheet-rich amyloid ﬁbrils stoichiometrically, and
the bound formdisplays a characteristic red shift in itsmaximum absor-
bance from 490 to 550 nm [33,34]. Based on absorbance at 550 nm
which is representing the amounts of Tau ﬁbrils, we can quantitatively
characterize Tau ﬁbrillization induced by Congo red. Thirdly, Congo
red is able to cross the membrane and has thus been employed as an
agonist into an inducible cell model for some amyloidogenic proteinsTEMmeasurements. Negative-stain transmission electronmicrographs of 5 μMwild-type
μMTau244–372/ΔPHF6/ΔPHF6* (c), and 5 μMTau244–372/ΔPHF6/ΔPHF6* inserted by GGGG
, c, and d). Amyloid ﬁbrils were clearly observed in a and b. In contrast, no aggregateswere
1566 X.-L. Liu et al. / Biochimica et Biophysica Acta 1852 (2015) 1561–1573[26]. Fig. 1a and b shows amyloid ﬁbril formation of wild-type
Tau244–372 induced by Congo red at 0 and 2 h, respectively, and
Fig. 1c and d shows that of Tau244–372/ΔPHF6/ΔPHF6* inserted by
IFQINS at the location of PHF6 (positive insertion mutant) induced by
Congo red at 0 and 12 h, respectively. Fig. S1A and B displays amyloid ﬁ-
bril formation of Tau244–372/ΔPHF6 induced by Congo red at 0 and 12 h,
respectively, and Fig. S1C and D displays that of Tau244–372/ΔPHF6* in-
duced by Congo red at 0 and 12 h, respectively. As shown in Figs. 1 and
S1, the absorbance of Tau was almost unobservable between 400 and
650 nm, and Congo red had a characteristic absorbance peak at around
490 nm. A red shift of the maximum absorbance of Congo red from
490 nm to 550 nm occurred for wild-type Tau244–372, its positive inser-
tion mutant, PHF6-deleted mutant, and PHF6*-deleted mutant in the
presence of 50 μM Congo red (Fig. 1b and d, and Fig. S1B and D), which
is one of the characteristic features of amyloid ﬁbrils [33,34]. In contrast,Fig. 5. Sequence-dependent abnormal aggregation of human Tau244–372 in SH-SY5Y cells. Wild
PHF6 (d–f) over-expressed in SH-SY5Y neuroblastoma cells formed aggregates in the cells. In c
SH-SY5Y cells (g–i) or Tau244–372/ΔPHF6/ΔPHF6* inserted by GGGGGG at the location of P
coimmunostained with primary monoclonal antibodies anti-FLAG and secondary Alexa Fluo-5in the presence of 50 μMCongo red, no red shift of the maximum absor-
bance of this dye was observed for either Tau244–372/ΔPHF6/ΔPHF6*
(double deletion mutant) or Tau244–372/ΔPHF6/ΔPHF6* inserted by
GGGGGGat the location of PHF6 (negative insertionmutant), and the ab-
sorbance spectrum of Tau + Congo red was almost the same as that of
Congo red alone (Fig. 1f and h), indicating that no aggregation was de-
tected when either the double deletion mutant or the negative
insertion mutant was incubated with this inducer up to 12 h. Our
Congo red binding data indicate that ﬁbril-forming motifs are essential
and sufﬁcient for the ﬁbrillization of human Tau244–372 induced by
Congo red in vitro.
Aggregation kinetics can be achieved by detecting the absorbance at
550 nm continuously (Figs. 2 and 3). We then used a sigmoidal
equation [8,9,31,32] to ﬁt the kinetic data, in order to elucidate the de-
tailed effects of Congo red on amyloid ﬁbril formation of wild-type-type Tau244–372 (a–c) and Tau244–372/ΔPHF6/ΔPHF6* inserted by IFQINS at the location of
ontrast, no aggregates were observed in either Tau244–372/ΔPHF6/ΔPHF6* over-expressed
HF6 over-expressed SH-SY5Y cells (j–l). SH-SY5Y cells were stained with 250 μM ThT,
46, and visualized by confocal microscopy. The scale bar represents 10 μm.
Fig. 6. Fibril-formingmotifs are essential and sufﬁcient for abnormal aggregation of human
Tau244–372 in SH-SY5Y cells — Western blot. Wild-type Tau244–372 (a) and Tau244–372/
ΔPHF6/ΔPHF6* inserted by IFQINS at the location of PHF6 (b) over-expressed in SH-SY5Y
neuroblastoma cells formed aggregates in the cells. In contrast, no aggregateswere observed
in either Tau244–372/ΔPHF6/ΔPHF6* expressed SH-SY5Y cells (c) or Tau244–372/ΔPHF6/
ΔPHF6* inserted by GGGGGG at the location of PHF6 over-expressed SH-SY5Y cells
(d). Immunoreactive bands were visualized by enhanced chemiluminescence. Immunoblots
for cell lysates, and ultracentrifugation pellets, and β-actin were shown.
1567X.-L. Liu et al. / Biochimica et Biophysica Acta 1852 (2015) 1561–1573Tau244–372 and its mutants. Three kinetic parameters, k, tm, and the lag
time, were determined by ﬁtting the absorbance at 550 nm versus
time to this equation, and the best ﬁt to each data set, calculated using
the parameter values given in Table 1, was plotted together with the
data in Figs. 2 and 3. As shown in Table 1, the optimal molar ratio of
Congo red to wild-type Tau244–372 is 10:1 for the shortest lag time,
which is similar to the optimal molar ratio of Congo red to full-length
human Tau as previously reported [25,26].
To get a better understanding about the effect of Congo red on Tau
aggregation, we performed kinetic analyses based on the absorbance
at 550 nm using the optimal molar ratio of Congo red to Tau of 10:1.
As is shown in Fig. 3 and Table 1, aggregation was observed for both
wild-type Tau244–372 and its positive insertion mutant in the presence
of 50 μM Congo red (Fig. 3a and b). In contrast, no aggregation was de-
tectedwhen either the double deletionmutant or the negative insertion
mutant was incubated with 50 μMCongo red up to 12 h (Fig. 3c and d).
The above data once again demonstrate that ﬁbril-forming motifs
are essential and sufﬁcient for the ﬁbrillization of human Tau244–372
induced by Congo red in vitro.
To further prove Congo red induced Tau aggregation in vitro, TEM
was employed to study the morphology of Tau incubated with Congo
red. Amyloid ﬁbrils were clearly observed in negative-stain transmis-
sion electron micrographs of both wild-type Tau244–372 and its positive
insertion mutant in the presence of 50 μM Congo red (Fig. 4a and b).
As shown in Fig. 3a and b and Fig. 4a and b, ﬁbrils formed from
wild-type Tau244–372 and its positive insertion mutant were of different
kinetic parameters and different morphologies. Wild-type Tau244–372
produced abundant short amyloid ﬁbrils at 45 min (Fig. 4a) and abun-
dant long and branched ﬁbrils at 12 h (data not shown) with shorter
lag time (Fig. 3a), but the positive insertion mutant produced some
short ﬁlaments and many ﬁbrils with a length of 100–200 nm at 12 h
(Fig. 4b) withmuch longer lag time (Fig. 3b). By contrast, no aggregates
were observed when either the double deletion mutant or the negative
insertion mutant was incubated with Congo red up to 12 h (Fig. 4c
and d). We could address such distinct kinetics and morphologies in
light of sequence-dependent abnormal aggregation of Tau. However,
the possibility that changes in structures and/or solubility of Tau result
in such distinct kinetics and morphologies cannot be excluded.
We concluded from the results of TEM and Congo red binding assay
that human Tau aggregation induced by Congo red is sequence-
dependent in vitro. When its two ﬁbril-forming segments PHF6 and
PHF6* were deleted, human Tau fragment Tau244–372 did lose its ability
to form ﬁbrils induced by Congo red, and the insertion of an unrelated
amyloid core sequence IFQINS from human lysozyme into the disabled
Tau protein did retrieve its ability to form ﬁbrils. By contrast, insertion
of a non-ﬁbril forming peptide GGGGGG did not drive the disabled
Tau protein to misfold in vitro.
3.2. Fibril-forming motifs are essential and sufﬁcient for Tau ﬁbrillization in
SH-SY5Y cells
Here, we ﬁrst established an inducible cell model which used Congo
red as the agonist to examinewhether the aggregation of human Tau in
SH-SY5Y neuroblastoma cells is sequence-dependent or not. SH-SY5Y
cells transiently over-expressing FLAG-tagged wild-type Tau244–372,
the positive insertion mutant, PHF6-deleted mutant, PHF6*-deleted
mutant, the double deletion mutant, and the negative insertion mutant
were incubated with 10 μM Congo red for 3 days, planted onto the
coverslips in the presence of 10 μM Congo red for 3 days, and then
transfected with plasmids transiently (Figs. 5 and S2). As shown in
Figs. 5 and S2, wild-type Tau244–372 (a–c), its positive insertion mutant
(d–f), PHF6-deleted mutant (a–c), and PHF6*-deleted mutant (d–f)
over-expressed in SH-SY5Y cells formed aggregates in the cells, as
detected by immunoﬂuorescence using anti-FLAG antibody (red) and
ThT staining (green), an amyloid-binding dye, and the merge image
(light gray or white) demonstrated co-localization of transiently over-expressed wild-type Tau244–372 or its positive insertion mutant or its
single deletion mutants with ThT-positive amyloids. In contrast, no ag-
gregates were observed in either the double deletionmutant (Fig. 5g–i)
or the negative insertion mutant (Fig. 5j–l) over-expressed SH-SY5Y
cells, since co-localization of immunoﬂuorescence and ThT staining
was invisible as detected by immunoﬂuorescence using anti-FLAG
antibody (red) and ThT staining (green invisible). Therefore, we ﬁrst
demonstrated sequence-dependent abnormal aggregation of human
Tau in SH-SY5Y cells induced by Congo red.
Because the cells were exposed to 10 μM Congo red for extended
periods of time, and might react differently from naive cells, we did
the following control experiment with pathogenic mutations that
favor Tau aggregation in the absence of Congo red (Fig. S3). As shown
in Fig. S3b and c, some of the ThS stain is outside of cells expressing
Tau244–372ΔK280, as indicated by anti-FLAG immunostaining. As
shown in Fig. S3, both Tau244–372ΔK280 stably expressed in SH-SY5Y
cells (a–d) and endogenous human Tau (e–h) formed aggregates in
the cells even in the absence of Congo red, as detected by immunoﬂuo-
rescence using anti-FLAG antibody (red) or TAU-5 (red) and ThS
staining (green), another amyloid-binding dye, and the merge
image (white) demonstrated co-localization of both stably expressed
Tau244–372ΔK280 and endogenous human Tau with ThS-positive
amyloids. Clearly, ThS staining is detecting both endogenous human
Tau aggregates and Tau244–372ΔK280 aggregates in Fig. S3b and c.
Therefore, abnormal aggregation of human Tau in SH-SY5Y cells is
sequence-dependent but not Congo red-dependent.
Then,we appliedWesternblot to conﬁrmCongo red induced Tau ag-
gregation in Tau over-expressed SH-SY5Y cells. SH-SY5Y cell lysis was
separated into supernatant and pellet fractions by ultracentrifugation.
Western blot bands in a and b of cell lysate were present to conﬁrm
that wild-type Tau244–372 and its mutants did over-express in SH-SY5Y
cells (Figs. 6 and S4).Wild-type Tau244–372, its positive insertionmutant,
PHF6-deleted mutant, and PHF6*-deleted mutant over-expressed in
SH-SY5Y cells formed aggregates in the cells, as observed in the pellet
fraction (Fig. 6a and b and Fig. S4a and b). By contrast, no aggregates
were observed in either the double deletion mutant or the negative
insertionmutant over-expressed SH-SY5Y cells, since the pellet fraction
was invisible (Fig. 6c and d).
To further conﬁrm sequence-dependent ﬁbril formation of human
Tau in SH-SY5Y cells, immunogold electron microscopy was applied
to survey the morphology of Tau aggregates extracted from Congo
red-treated, Tau over-expressed SH-SY5Y cells and visualized by
immunoelectronmicroscopy usingmonoclonal anti-FLAG primary anti-
body and 10-nmgold-labeled secondary antibody. Aggregates extracted
from wild-type Tau244–372 and its positive insertion mutant over-
expressed SH-SY5Y cells were labeled by gold particles, and ﬁbrils
highlighted by using red arrowheads were observed in both cases
(Fig. 7a and b). We conclude that such ﬁlaments are composed of Tau
protein from these stains. In contrast, no aggregates were observed in
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over-expressed SH-SY5Y cells (Fig. 7c and d).
Combining the results from immunoﬂuorescence, Western blot, and
immunogold electron microscopy, we conclude that ﬁbril-forming mo-
tifs are essential and sufﬁcient for abnormal aggregation of human Tau
in SH-SY5Y cells induced by Congo red: when its two ﬁbril-forming seg-
ments PHF6 and PHF6* are deleted, human Tau fragment Tau244–372 did
lose its ability to form ﬁbrils in SH-SY5Y cells, and the replacement
of PHF6 and PHF6* with an unrelated amyloidogenic sequence
IFQINS from human lysozyme did rescue the ﬁbril-forming ability of
Tau244–372 in SH-SY5Y cells. These ﬁbril-forming motifs themselves
(PHF6, PHF6*, and IFQINS) can form amyloid ﬁbrils in vitro and in cells
[13,14]. We demonstrate for the ﬁrst time that insertion of such a
ﬁbril-forming motif can replace PHF6/PHF6* motifs, forcing humanFig. 7. Fibril-formingmotifs are essential and sufﬁcient for theﬁbrillization of human Tau244–372
Tau244–372 (a) and Tau244–372/ΔPHF6/ΔPHF6* inserted by IFQINS at the location of PHF6 (b)wer
in both cases (a and b). In contrast, no aggregates were observed in either Tau244–372/ΔPHF6/ΔP
at the location of PHF6 over-expressed SH-SY5Y cells (d). The scale bars represent 100 nm.Tau to form ﬁbrils in cells. By contrast, insertion of a non-ﬁbril forming
peptide GGGGGG did not drive the disabled Tau244–372 to misfold in
SH-SY5Y cells.
3.3. Fibril-forming motifs are essential and sufﬁcient for early apoptosis of
living SH-SY5Y cells induced by abnormal aggregation of human Tau
As mentioned above, Tau244–372 formed amyloid ﬁbrils induced by
Congo red both in vitro and in SH-SY5Y cells, we want to knowwhether
such abnormal aggregation can induce early apoptosis of SH-SY5Y
cells. In the early stages of apoptosis, the cell membrane can expose
phosphatidylserine which is annexin V-positive [35]. We then apply
Q-dots based probes combined with annexin V staining to detect early
apoptosis of living SH-SY5Y cells induced by abnormal aggregation ofin SH-SY5Y cells— immunogold electronmicroscopy. Aggregates extracted fromwild-type
e labeled by gold particles, and ﬁbrils, highlighted by using red arrowheads, were observed
HF6* over-expressed SH-SY5Y cells (c) or Tau244–372/ΔPHF6/ΔPHF6* inserted by GGGGGG
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monomers can be transported into living SH-SY5Y cells conveniently.
Apoptotic cells were stained with an Annexin V-conjugated organic
dye FITC. As shown in Fig. 8, wild-type Tau244–372monomer, the positive
insertion mutant monomer, the double deletion mutant monomer, and
the negative insertion mutant monomer, all labeled by Q-dots (red),
entered into living SH-SY5Y cells through endocytosis, and mainly lo-
cated in the cytoplasm. Wild-type Tau244–372 monomer (Fig. 8a–d)
and its positive insertion mutant monomer (Fig. 8e–h) marked by
Q-dots formed aggregates and thus induced early apoptosis of living
SH-SY5Y cells, as marked by Annexin V-FITC (green) binding to
phosphatidylserine moieties on the outer membrane of the cells
(Fig. 8b, c, f, and g). In contrast, such early apoptosis of living SH-SY5Y
cells was not observed in either the double deletion mutant monomerFig. 8. Fibril-forming motifs are essential and sufﬁcient for early apoptosis of living SH-SY5Y c
combined with annexin V staining. Wild-type Tau244–372 monomer (a–d) and Tau244–372/ΔPHF
dots formed aggregates and thus induced early apoptosis of living SH-SY5Y neuroblastoma cells
ΔPHF6* (i–l) or Tau244–372/ΔPHF6/ΔPHF6* inserted by GGGGGG at the location of PHF6 mark
observed by confocal laser scanning microscopy. The scale bar represents 10 μm.(Fig. 8i–l) or the negative insertion mutant monomer (Fig. 8m–p)
marked by Q-dots (Fig. 8j, k, n, and o). Furthermore, no early apoptosis
was observed either in living SH-SY5Y cells cultured in Congo red alone
(Fig. S6a) or in living SH-SY5Y cells cultured in Congo red incubated
with Q-dots (Fig. S6b), indicating that either Congo red itself or Q-dots
themselves cannot induce apoptosis of SH-SY5Y cells.
The difference between apoptosis and cell necrosis is that during the
early stages of apoptosis the cell membrane remains intact, while
during necrosis the cell membrane loses its integrity and becomes
leaky [36]. Therefore the measurement of annexin V binding to the
cell surface as indicative for apoptosis should be performed in combina-
tionwith themembrane-impermeable DNA stain PI to distinguish three
different cell types during apoptosis: viable cells (annexin V- and PI-
negative), early apoptotic cells (annexin V-positive but PI-negative),ells induced by abnormal aggregation of human Tau244–372— quantum dots based probes
6/ΔPHF6* monomer inserted by IFQINS at the location of PHF6 (e–h) marked by quantum
. In contrast, early apoptosis of SH-SY5Y cells was not observed in either Tau244–372/ΔPHF6/
ed by quantum dots (m–p). Living SH-SY5Y cells were stained with Annexin V-FITC, and
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Here, we performed double-staining using annexin V-FITC and PI
followed by ﬂow cytometry. As shown in Fig. 9, the percentage of
early apoptotic cells in Congo red cultured living SH-SY5Y cells incubat-
ed with wild-type Tau244–372 monomer (a) and its positive insertion
mutant monomer (b) for 12 h was 19.50% and 11.48% respectively,
much higher than that of the double deletion mutant (c, 3.90%) and
the negative insertion mutant (d, 3.08%), while only a very small
amount of Congo red cultured living SH-SY5Y cells incubated with
wild-type Tau244–372 and its three mutants for 12 h was late apoptotic
or necrotic. In order to distinguish between Tau fragment toxicity and
toxicity that occur only in the presence of Congo red, we did the follow-
ing control experiments and performed statistical analyses by using the
Student's t-test (Fig S7). As shown in Fig. S7, Congo red itself had no tox-
icity and even nutritious to SH-SY5Y cells. Our control experiments
demonstrated that Congo red treatment is actually nutritious to the
cells (Fig. S7).
Combining the results from quantum dots based probes combined
with annexin V staining and annexin V-FITC apoptosis detection assay,
we conclude that ﬁbril-forming motifs are essential and sufﬁcient for
early apoptosis of living SH-SY5Y cells induced by abnormal aggregationFig. 9. Flow cytometric analysis of annexin V and PI staining shows induction of apoptosis. Con
Tau244–372/ΔPHF6/ΔPHF6* monomer inserted by IFQINS (b) for 12 h showed much higher ra
ΔPHF6/ΔPHF6* monomer inserted by GGGGGG (d) for 12 h. The percentage of apoptotic cel
3.0 software. Viable cells did not bind annexin V or PI (lower left quadrant D3), early apopto
late apoptotic cells were both annexin V- and PI-positive (upper right quadrant D2). The upperof human Tau. We demonstrate for the ﬁrst time that insertion of a
ﬁbril-forming motif IFQINS can replace PHF6/PHF6* motifs, forcing
human Tau to form ﬁbrils in living cells and inducing early apoptosis
of living cells.
4. Discussion
Amyloidogenic proteins, including humanTau [3,7,11,12], amyloidβ
[37], human α-synuclein [38], and human copper, zinc superoxide dis-
mutase [39], have been investigated in vivo to a certain degree.
Amyloidogenic proteins studied in vivo could be muchmore signiﬁcant
for the treatment of neurodegenerative diseases. Investigations on
human Tau in cells generally focus on its aggregation, which are suc-
cessful by using agonist inducers [26,27], ﬁbril seeds [40,41], and its
pathological mutant-ΔK280 [42–44] to promote its ﬁbrillization. In
this study, we employed a Congo red inducible cell model to investigate
abnormal aggregation of human Tau in SH-SY5Y cells. We found that
ﬁbril-forming motifs are essential and sufﬁcient not only for the
ﬁbrillization of human Tau in SH-SY5Y cells, but also for early apoptosis
of living SH-SY5Y cells induced by abnormal aggregation of human Tau.
Our results suggest that ﬁbril-formingmotifs could be the determinantsgo red cultured living SH-SY5Y cells incubated with wild-type Tau244–372 monomer (a) or
te of early apoptosis than that of Tau244–372/ΔPHF6/ΔPHF6* monomer (c) or Tau244–372/
ls was detected by analyzing annexin V-FITC and PI binding with the help of the Submit
tic cells bound to annexin V but excluded PI (lower right quadrant D4), and necrotic or
left quadrant D1 contains the cells damaged during the preparation of the cell suspension.
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neuronal apoptosis and causing the initiation and development of
tauopathies. The data of positive and negative control mutants with
double deletion mutants increased reliability of our suggestion.
Congo red, being a commonly used histological dye for amyloid de-
tection, possesses the capacity to interfere with processes of protein
misfolding and aggregation [45]. Its absorbance peak displays a red
shift in UV–visible absorbance spectrum after binding ﬁbrils and it is a
diagnostic stain presenting characteristic apple-green birefringence
[27,33,34,46]. Congo red has been found to bind to the prion-forming
domain of HET-s prion with a ten-fold molar excess of Congo red [47].
Heteronuclear NMR data also show that Congo red at lower concentra-
tions mainly interacts with the N-terminal and central regions of
α-synuclein, binding to monomeric α-synuclein and promoting
ﬁbrillization [48]. Congo red at lower concentrations also populates par-
tially unfolded states of an amyloidogenic protein to enhance amyloid
ﬁbril formation [49]. However, Congo red at higher concentrations sta-
bilizes amyloid β monomer, inhibits its oligomerization, and reduces
β-amyloid neurotoxicity [50]. Congo red at higher concentrations also
blocks the structural conversion of normal prion protein into its
aggregation-competent pathogenic form [51,52]. The kinetic barrier to
Tau ﬁbrillization can be overcome by Congo red [25]. Considering its
transmembrane ability, Congo red has been employed as an agonist
into an inducible cell model for some amyloidogenic proteins [26]. We
ﬁrstly studied the effect of Congo red on ﬁbril formation of human Tau
fragments in vitro, and found that human Tau aggregation induced by
Congo red is sequence-dependent in vitro. When its two ﬁbril-forming
segments PHF6 and PHF6* were deleted, human Tau244–372 did lose its
ability to form ﬁbrils induced by Congo red, and the insertion of an un-
related amyloid core sequence into the disabled Tau244–372 did retrieve
its ability to form ﬁbrils. By contrast, insertion of a non-ﬁbril forming
peptide did not drive the disabled Tau244–372 tomisfold in vitro. Very re-
cently, it has been demonstrated that deletion of PHF6 and PHF6* does
abolish the seeding activity of recombinant full-length Tau, suggesting
that its aggregation is necessary for seeding [53]. We then investigated
sequence-dependent abnormal aggregation of human Tau244–372 in an
inducible cell model by using Congo red as an agonist, and found that
that PHF6 and PHF6* facilitated ﬁbril formation of Tau244–372 in
SH-SY5Y cells cultured in the presence of Congo red. We also foundFig. 10. A hypothetical model to explain why ﬁbril-forming motifs are so important for driving
Tau244–372 and its positive insertionmutant (native Taumonomers, blue),with ﬁbril-formingm
entering into SH-SY5Y cells via endocytosis, can form ﬁbrils and enhance hyperphosphorylation
inducing early apoptosis of living SH-SY5Y cells.that an exogenous ﬁbril-forming motif from human lysozyme was
able to facilitate ﬁbril formation of this Tau fragment in this cell system.
In other words, insertion of other ﬁbril-forming motifs can replace the
corresponding motifs of Tau fragment, forcing Tau fragment to form ﬁ-
brils in cells. A higher percentage of SH-SY5Y cells expressing ﬁbril-
forming sequences displayed early stages of apoptosis accompanied
by a potential phosphorylation of endogenous human Tau in SH-SY5Y
cells that have internalized ﬁbril-forming Tau244–372, while non-ﬁbril
forming polypeptides had no effect.
Fibril formation of human Tau protein is associated with AD. This
paper investigated structural requirements for Tau aggregation inside
cultured cells. We focus on the PHF6 and PHF6* motifs previously iden-
tiﬁed as being essential on the basis of in vitro experimentation [19–21].
In our previously published work [19], we showed that the PHF6/PHF6*
motifs could be replaced by exogenous amyloidogenic hexapeptidemo-
tifs when analyzed in the presence of heparin aggregation inducer. The
present study ﬁrstly investigated sequence-dependent ﬁlament forma-
tion of human Tau in cells, inducing early apoptosis of living cells. In the
current work, we conﬁrmed the need for at least one amyloidogenic
motif in Tau to support aggregation of Tau244–372in vitro using Congo
red as aggregation inducer (a membrane-permeable inducer). We also
found that a single amyloidogenic hexapeptide motif at the PHF6 site
was necessary and sufﬁcient to support Tau aggregation and toxicity
(in the form of apoptosis) in SH-SY5Y cellular environment. Therefore,
this paper provides evidence for the conclusion that ﬁbril-forming mo-
tifs are essential and sufﬁcient for Tau ﬁbrillization in living cells, much
more strongly than our previous study [19]. Clearly, Tau aggregation
and toxicity depended on sequences of Tau. However, more than
sequence, changes in structures and/or solubility would be alternative
explanations. From a macroscopic viewpoint, formation of amyloid
ﬁbrils and amorphous aggregates never happens otherwise concentra-
tions of monomers exceed their solubility. Alternatively, changing to
amyloidogenic structures (populating amyloidogenic structures) by
mutation could be a microscopic explanation.
Based on our owndata,we propose a valuable hypotheticalmodel to
explain why ﬁbril-forming motifs are so important for driving human
Tau to form ﬁbrils in cells (Fig. 10). In the presence of Congo red,
wild-type human Tau monomer and its positive insertion mutant
monomer, both with ﬁbril-forming motif(s), either over-expressed inhuman Tau to form ﬁbrils in cells. In the presence of Congo red (red stick), both wild-type
otifs (pink), either over-expressed in SH-SY5Y cells ormarkedby quantumdots (red circle)
of endogenous human Tau (purple; phosphorylation site, green) in SH-SY5Y cells, thereby
1572 X.-L. Liu et al. / Biochimica et Biophysica Acta 1852 (2015) 1561–1573cells or marked by Q-dots entering into cells possibly via endocytosis,
can form ﬁbrils, thereby inducing early apoptosis of living cells. There-
fore, our data provide strong evidence that such a possible endocytosis
of human Tau monomers with ﬁbril-forming motif(s) is sufﬁcient to
initiate Tau pathology [54,55]. In contrast, none of aggregates and
early apoptosis was observed for the double deletion mutant and the
negative insertion mutant in living cells. Therefore, insertion of non-
ﬁbril forming peptides could be a novel strategy for neurodegenerative
disease therapeutics, and ﬁbril-forming units could be molecular bases
of prion-like propagation of protein pathology [56]. We claim a link
between Tau aggregation and toxicity in the form of apoptosis.
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